- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Impedimed Ltd (IPD)
The Impedimed share price today is 0.014, view ASX IPD stock exchange data. Track the latest Impedimed share price with real-time updates on IPD stock performance including market cap, day range, 52-week range and dividend yield. Access IPD charts, earnings dates and analyst estimates to support your investment decisions.
Sydney
Currency in AUD
0.014
0.000(0.00%)
Delayed Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.014
0.014
52 wk Range
0.013
0.059
IPD is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0140.014
52 wk Range
0.0130.059
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
IPD Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
0.048
Upside
+239.29%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
- Impedimed Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Impedimed Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Impedimed Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Impedimed Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Impedimed Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Impedimed Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy
Analyst Ratings
4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 0.048
(+239.29% Upside)
Earnings
Latest Release
30-04-2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / 4.6M
Compare IPD to Peers and Sector
Metrics to compare | IPD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIPDPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.2x | −3.5x | −0.5x | |
PEG Ratio | 0.08 | −0.05 | 0.00 | |
Price/Book | 3.2x | 5.9x | 2.6x | |
Price / LTM Sales | 2.0x | 4.2x | 3.2x | |
Upside (Analyst Target) | 257.1% | 69.5% | 48.8% | |
Fair Value Upside | Unlock | 15.5% | 6.9% | Unlock |
ImpediMed Limited, a medical technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) technology medical devices and software services in Australia, Europe, the United States, and internationally. The company offers SOZO, a noninvasive BIS device for the clinical assessment of lymphedema, which uses bioimpedance measurements to assess fluid levels and tissue composition; L-Dex analysis for lymphedema; BodyComp Analysis, a point-of-care body composition analysis; and HF-Dex analysis for point-of-care heart failure fluid assessment. It also provides SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. ImpediMed Limited was incorporated in 1999 and is headquartered in Carlsbad, California with additional office in Lindfield, Australia.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Impedimed (IPD) Share Price Today?
The Impedimed share price today is 0.014.
What is the current Impedimed (IPD) share price and day range?
As of 01-05-2026, the Impedimed share price is 0.014, with a previous close of 0.014. The share price has ranged from 0.014 to 0.014 today, while the 52-week range spans from 0.013 to 0.059.
What Is the Impedimed Market Cap?
As of today, Impedimed market cap is 28.540M.
What Is the Impedimed (IPD) Share Price Target?
The average 12-month share price target for Impedimed is 0.048, with a high estimate of 0.06 and a low estimate of 0.03. 4 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +239.29% Upside potential.
What Is Impedimed's Earnings Per Share (TTM)?
The Impedimed EPS (TTM) is -0.012.
When Is the Next Impedimed Earnings Date?
Impedimed will release its next earnings report on 27-08-2026.
From a Technical Analysis Perspective, Is IPD a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does Impedimed Trade On?
Impedimed is listed and trades on the Sydney Stock Exchange.
What Is the Stock Symbol for Impedimed?
The stock symbol for Impedimed is "IPD."
How Many Times Has Impedimed Stock Split?
Impedimed has split 6 times.
How Many Employees Does Impedimed Have?
Impedimed has 77 employees.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.